Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells
Authors
Keywords
-
Journal
eLife
Volume 7, Issue -, Pages -
Publisher
eLife Sciences Organisation, Ltd.
Online
2018-05-01
DOI
10.7554/elife.34655
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells
- (2017) Anwesha Sanyal et al. NATURE MEDICINE
- HIV persistence in tissue macrophages of humanized myeloid-only mice during antiretroviral therapy
- (2017) Jenna B Honeycutt et al. NATURE MEDICINE
- Multiple Histone Lysine Methyltransferases Are Required for the Establishment and Maintenance of HIV-1 Latency
- (2017) Kien Nguyen et al. mBio
- In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a “Block-and-Lock” Strategy for HIV-1 Treatment
- (2017) Cari F. Kessing et al. Cell Reports
- High-throughput Characterization of HIV-1 Reservoir Reactivation Using a Single-Cell-in-Droplet PCR Assay
- (2017) Robert W. Yucha et al. EBioMedicine
- The mTOR Complex Controls HIV Latency
- (2016) Emilie Besnard et al. Cell Host & Microbe
- The role of HIV integration in viral persistence: no more whistling past the proviral graveyard
- (2016) Frank Maldarelli JOURNAL OF CLINICAL INVESTIGATION
- Comparative Analysis of HIV-1 and Murine Leukemia Virus Three-Dimensional Nuclear Distributions
- (2016) Valentina Quercioli et al. JOURNAL OF VIROLOGY
- Defective proviruses rapidly accumulate during acute HIV-1 infection
- (2016) Katherine M Bruner et al. NATURE MEDICINE
- Position effects influence HIV latency reversal
- (2016) Heng-Chang Chen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin
- (2016) Gregory A. Sowd et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Latency reversal and viral clearance to cure HIV-1
- (2016) D. M. Margolis et al. SCIENCE
- Reversal of Latency as Part of a Cure for HIV-1
- (2016) Thomas Aagaard Rasmussen et al. TRENDS IN MICROBIOLOGY
- Shocking HIV out of hiding
- (2016) Thomas A. Rasmussen et al. Current Opinion in HIV and AIDS
- Position effects influence HIV latency reversal
- (2016) Heng-Chang Chen et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
- (2016) Lenard S. Vranckx et al. EBioMedicine
- Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner
- (2016) Hong Kim et al. Scientific Reports
- Understanding HIV Latency: The Road to an HIV Cure
- (2015) Matthew S. Dahabieh et al. Annual Review of Medicine
- Retroviral integration: Site matters
- (2015) Jonas Demeulemeester et al. BIOESSAYS
- HIV-1 Integration Landscape during Latent and Active Infection
- (2015) Lillian B. Cohn et al. CELL
- Ex vivo analysis identifies effective HIV-1 latency–reversing drug combinations
- (2015) Gregory M. Laird et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulation of HIV-1 Latency by Chromatin Structure and Nuclear Architecture
- (2015) Marina Lusic et al. JOURNAL OF MOLECULAR BIOLOGY
- H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat inEx VivoCultures of Resting CD4+T Cells
- (2015) Manoj K. Tripathy et al. JOURNAL OF VIROLOGY
- Nuclear architecture dictates HIV-1 integration site selection
- (2015) Bruna Marini et al. NATURE
- Synergistic Activation of Latent HIV-1 Expression by Novel Histone Deacetylase Inhibitors and Bryostatin-1
- (2015) Marta Martínez-Bonet et al. Scientific Reports
- An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression
- (2015) Gilles Darcis et al. PLoS Pathogens
- Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation
- (2015) Guochun Jiang et al. PLoS Pathogens
- The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
- (2015) Ole S. Søgaard et al. PLoS Pathogens
- Epigenetic control of HIV-1 post integration latency: implications for therapy
- (2015) Amit Kumar et al. Clinical Epigenetics
- Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study
- (2015) Julian H Elliott et al. Lancet HIV
- Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
- (2014) James B. Whitney et al. NATURE
- New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo
- (2014) C Korin Bullen et al. NATURE MEDICINE
- Transcriptional enhancers: from properties to genome-wide predictions
- (2014) Daria Shlyueva et al. NATURE REVIEWS GENETICS
- Quantification of HIV-1 latency reversal in resting CD4+ T cells from patients on suppressive antiretroviral therapy
- (2014) A. R. Cillo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Direct non-productive HIV-1 infection in a T-cell line is driven by cellular activation state and NFκB
- (2014) Matthew S Dahabieh et al. Retrovirology
- Intersection of population variation and autoimmunity genetics in human T cell activation
- (2014) C. J. Ye et al. SCIENCE
- Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection
- (2014) T. A. Wagner et al. SCIENCE
- Specific HIV integration sites are linked to clonal expansion and persistence of infected cells
- (2014) F. Maldarelli et al. SCIENCE
- Activation of HIV Transcription with Short-Course Vorinostat in HIV-Infected Patients on Suppressive Antiretroviral Therapy
- (2014) Julian H. Elliott et al. PLoS Pathogens
- Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
- (2014) Thomas A Rasmussen et al. Lancet HIV
- Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure
- (2013) Ya-Chi Ho et al. CELL
- BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism
- (2013) Daniela Boehm et al. CELL CYCLE
- Proximity to PML Nuclear Bodies Regulates HIV-1 Latency in CD4+ T Cells
- (2013) Marina Lusic et al. Cell Host & Microbe
- Recombination Can Lead to Spurious Results in Retroviral Transduction with Dually Fluorescent Reporter Genes
- (2013) D. J. Salamango et al. JOURNAL OF VIROLOGY
- A Doubly Fluorescent HIV-1 Reporter Shows that the Majority of Integrated HIV-1 Is Latent Shortly after Infection
- (2013) M. S. Dahabieh et al. JOURNAL OF VIROLOGY
- Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes
- (2013) Jocelyn O. Eidahl et al. NUCLEIC ACIDS RESEARCH
- HIV latency and integration site placement in five cell-based models
- (2013) Scott Sherrill-Mix et al. Retrovirology
- Dual-color HIV reporters trace a population of latently infected cells and enable their purification
- (2013) Vincenzo Calvanese et al. VIROLOGY
- Eliminating the latent HIV reservoir by reactivation strategies: Advancing to clinical trials
- (2013) Thomas Rasmussen et al. Human Vaccines & Immunotherapeutics
- An In-Depth Comparison of Latent HIV-1 Reactivation in Multiple Cell Model Systems and Resting CD4+ T Cells from Aviremic Patients
- (2013) Celsa A. Spina et al. PLoS Pathogens
- Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
- (2012) Liang Shan et al. IMMUNITY
- BET bromodomain inhibition as a novel strategy for reactivation of HIV-1
- (2012) Camellia Banerjee et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
- (2012) N. M. Archin et al. NATURE
- LEDGF (p75) promotes DNA-end resection and homologous recombination
- (2012) Mads Daugaard et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation
- (2012) Zichong Li et al. NUCLEIC ACIDS RESEARCH
- Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection
- (2012) N. M. Archin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional burst frequency and burst size are equally modulated across the human genome
- (2012) R. D. Dar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reactivation of Latent HIV-1 by Inhibition of BRD4
- (2012) Jian Zhu et al. Cell Reports
- Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing
- (2012) Madapura M. Pradeepa et al. PLoS Genetics
- Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2
- (2011) J. Friedman et al. JOURNAL OF VIROLOGY
- Transcriptional Bursting from the HIV-1 Promoter Is a Significant Source of Stochastic Noise in HIV-1 Gene Expression
- (2010) Abhyudai Singh et al. BIOPHYSICAL JOURNAL
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Bryostatin Modulates Latent HIV-1 Infection via PKC and AMPK Signaling but Inhibits Acute Infection in a Receptor Independent Manner
- (2010) Rajeev Mehla et al. PLoS One
- Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration
- (2010) A. L. Ferris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions
- (2008) Lars Guelen et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation